Dozens of unexpected genes are strongly linked to type 2 diabetes, new research from The Jackson Laboratory (JAX) shows. The ...

Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some individuals with type 1 diabetes experience cognitive differences, sometimes ...

David Novak and his late wife Wendy — who died from Type 1 diabetes complications in 2024 — spent their lives advocating for ...

Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16 ...

It's a running joke that a cure for type 1 diabetes is only five years away and has been for 50 years, but new stem cell trials and immune drugs hint that we're closer than ever to a functional cure ...

Are researchers getting closer to functionally curing type 1 diabetes? Image credit: Costfoto/NurPhoto via Getty Images. A woman with type 1 diabetes started producing her own insulin less than 3 ...

The cells in your pancreas, like people, can only handle so much stress before they start to break down. Certain stressors, such as inflammation and high blood sugar, contribute to the development of ...

In recent years, we have come to appreciate that loss or dysfunction of insulin-producing islet beta cells underlies virtually all major forms of diabetes mellitus. In type 1 diabetes, beta cells ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Sana Biotechnology collaborates with Mayo Clinic to focus on improving care in type 1 diabetes and accelerating development of SC451: Seattle and Rochester Wednesday, April 15, 20 ...